AF
HZNP

Advisornet Financial’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Advisornet Financial’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-23
Closed -$2.66K – 2525
2023
Q3 		$2.66K Buy
23
+4
+21% +$430 ﹤0.01% 1564
2023
Q2 		$1.95K Sell
19
-47
-71% -$4.96K ﹤0.01% 1727
2023
Q1 		$7.2K Buy
66
+47
+247% +$5.2K ﹤0.01% 1393
2022
Q4 		$2.16K Sell
19
-81
-81% -$6.73K ﹤0.01% 1656
2022
Q3 		$6K Sell
100
-5
-5% -$349 ﹤0.01% 1497
2022
Q2 		$8K Buy
105
+5
+5% +$473 ﹤0.01% 1419
2022
Q1 		$11K Sell
100
-24
-19% -$2.34K ﹤0.01% 1430
2021
Q4 		$13K Hold
124
– – ﹤0.01% 1424
2021
Q3 		$14K Buy
+124
New +$12.9K ﹤0.01% 1375
2020
Q2 		– Sell
-300
Closed -$9K – 2017
2020
Q1 		$9K Buy
+300
New +$10.2K ﹤0.01% 1308
2019
Q3 		– Sell
-135
Closed -$3K – 2034
2019
Q2 		$3K Buy
+135
New +$3.42K ﹤0.01% 1500

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Advisornet Financial's HZNP Position: Q4 2023 in Review

Advisornet Financial sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 23 shares — an estimated $2.66K sold.

Advisornet Financial first reported a position in HZNP in Q2 2019 and held it in 11 quarters. The position peaked at $14K in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Advisornet Financial reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Advisornet Financial sold 23 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.66K.
  • Advisornet Financial first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 11 quarters.
  • Advisornet Financial's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $14K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Advisornet Financial's 13F filing for Q4 2023, filed 19 Jan 2024.